NEUROPSYCHIATRY PORTFOLIO

You are here:
  1. Home
  2. Brand Portfolio
  3. Neuropsychiatry Portfolio
Show All Stroke Antiepileptics Neuro Supplement Alzheimers Antidepressants & Anxiolytics Neuropathic Pain Antimigraine Mood Stabilizers Antisychotic Muscle Relaxant
  • Neuropsychiatry

    Quteklas

    Quetiapine Fumarate

    Quetiapine fumarate is initially approved by the FDA in 1997 and is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder. Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high sensitivity to…

    Know More